Emerging drug trends are reshaping the substance use landscape, often faster than communities and providers can respond. Substances like kratom, “gas station heroin” (tianeptine), phenibut, and DXM are widely accessible yet poorly understood, creating new risks for patients and treatment systems alike.

Join Dr. Gilbert Schmidt, a BrightView Medical Director, as he dives into these trending grey market substances.

Attendees will be able to:

• Identify un- or underregulated substances with addiction or dependence potential
• Recognize clinical and behavioral presentations associated with these substances
• Apply appropriate screening and treatment considerations
• Understand regulatory and public safety implications

Attending this FREE event is worth one NAADAC-approved continuing education (CE) hour. Please check with your state board to confirm CE eligibility.

Registration

Virtual attendance will be limited to the first 1,000 participants. We expect strong interest, so please register early to secure your spot. Once registered, you’ll be guaranteed access to the event. Register here

This event is in no way associated with the QAC Local Management Board. All questions must be directed to BrightView Health at info@brightviewhealth.com.